Collegium Pharmaceutical Inc (STU:354)
€ 29.8 0.2 (0.68%) Market Cap: 968.63 Mil Enterprise Value: 1.67 Bil PE Ratio: 13.81 PB Ratio: 4.43 GF Score: 79/100

Collegium Pharmaceutical Inc at Needham Healthcare Conference (Virtual) Transcript

Apr 18, 2023 / 06:15PM GMT
Release Date Price: €20.8 (-0.95%)
Serge Belanger
Needham & Company, LLC - Analyst

Hi, good afternoon. I'm Serge Belanger. I'm one of the senior healthcare analysts at Needham. I want to welcome you to Needham's 22nd Annual Healthcare Conference. And for our next session, we have the Collegium Pharmaceuticals team. We have the CEO and President, Joe Ciaffoni; as well as the CFO, Colleen Tupper.

So I'll hand it over to Joe to get us started. He'll give us a quick overview of the company and then we'll go to questions. (Conference Instructions) So Joe, please.

Joe Ciaffoni
Collegium Pharmaceutical, Inc. - President & CEO

Great. And Serge, thank you as always, for the opportunity to participate in the conference. Colleen and I appreciate that opportunity very much. 2023 for Collegium is a year we're excited about. We believe 2023 will be a banner year, and that's what we're setting out to achieve. We're proud of our leading commercial portfolio.

We have a strong financial position, and we're committed to taking a disciplined approach to capital deployment with the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot